Gartisertib
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-136270-5MG | 5 mg | 508,00 | Add | |
| HY-136270-1ML | 10mM/1mL | 603,00 | Add | |
| HY-136270-10MG | 10 mg | 837,00 | Add | |
| HY-136270-25MG | 25 mg | 1'660,00 | Add | |
| HY-136270-50MG | 50 mg | 2'420,00 | Add | |
| HY-136270-100MG | 100 mg | 3'624,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Gartisertib (VX-803) is an ATP-competitive, orally active, and selective ATR inhibitor, with a Ki of <150 pM. Gartisertib potently inhibits ATR-driven phosphorylated checkpoint kinase-1 (Chk1) phosphorylation with an IC50 of 8 nM. Antitumor activity[1][2].
| Category | Inhibitor |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Cell Cycle/DNA Damage,PI3K/Akt/mTOR |
| Format | Solubility: DMSO : 25 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.76% |
| Molecular Formula | C25H29F2N9O3 |
| Molecular Weight | 541.55 |
| CAS-Number | 1613191-99-3 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
